We are live on ! Find out more
PTJ

Paul Tudor Jones Tudor Investment Corp

AUM $71.9B
1-Year Est. Return 42.37%
 

Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.

This Fund
S&P 500
This Quarter Est. Return
+2.36%
1 Year Est. Return
+42.37%
3 Year Est. Return
+108.76%
5 Year Est. Return
+114.43%
10 Year Est. Return
+640.77%
AUM
$3.09B
AUM Growth
-$851M
Cap. Flow
-$836M
Cap. Flow %
-27.07%
Top 10 Hldgs %
59.08%
Holding
1,419
New
356
Increased
293
Reduced
289
Closed
452

Sector Composition

Rank Sector Weight
1 Technology 10.74%
2 Financials 7%
3 Industrials 6.15%
4 Consumer Discretionary 6.06%
5 Healthcare 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETFC
1351
DELISTED
E*Trade Financial Corporation
ETFC
-91,374
Closed -$4.53M
CCMP
1352
DELISTED
CMC Materials, Inc. Common Stock
CCMP
-3,503
Closed -$330K
WUBA
1353
DELISTED
58.com Inc
WUBA
-5,380
Closed -$385K
ENT
1354
DELISTED
Global Eagle Entertainment Inc.
ENT
-717
Closed -$41K
BGG
1355
DELISTED
Briggs & Stratton Corp.
BGG
-18,109
Closed -$459K
PTLA
1356
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-7,580
Closed -$369K
PGNX
1357
DELISTED
Progenics Pharmaceuticals Inc
PGNX
-31,817
Closed -$189K
CSFL
1358
DELISTED
CenterState Bank Corporation Common Stock
CSFL
-10,247
Closed -$264K
JCP
1359
DELISTED
J.C. Penney Company, Inc.
JCP
-167,653
Closed -$530K
AGN
1360
DELISTED
Allergan plc
AGN
-36,855
Closed -$6.03M
RTN
1361
DELISTED
Raytheon Company
RTN
-16,190
Closed -$3.04M
IPHS
1362
DELISTED
Innophos Holdings, Inc.
IPHS
-5,229
Closed -$244K
ACHN
1363
DELISTED
Achillion Pharmaceuticals
ACHN
-245,820
Closed -$708K
MDCO
1364
DELISTED
Medicines Co
MDCO
-9,404
Closed -$257K
ONCE
1365
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
-8,864
Closed -$456K
CJ
1366
DELISTED
C&J Energy Services, Inc.
CJ
-21,916
Closed -$734K
RTEC
1367
DELISTED
Rudolph Technologies Inc
RTEC
-11,044
Closed -$264K
CHSP
1368
DELISTED
Chesapeake Lodging Trust
CHSP
-12,054
Closed -$327K
WP
1369
DELISTED
Worldpay, Inc.
WP
-15,102
Closed -$1.11M
TVPT
1370
DELISTED
Travelport Worldwide Limited
TVPT
-20,666
Closed -$270K
BEL
1371
DELISTED
Belmond Ltd.
BEL
-14,939
Closed -$183K
ARRS
1372
DELISTED
ARRIS International plc Ordinary Shares
ARRS
-60,967
Closed -$1.57M
ICON
1373
DELISTED
Iconix Brand Group, Inc.
ICON
-2,001
Closed -$26K
SGYP
1374
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
-162,236
Closed -$362K
ITG
1375
DELISTED
Investment Technology Group Inc
ITG
-11,237
Closed -$216K

Similar funds

Paul Tudor Jones's Q1 2018 Portfolio in Review

As of Q1 2018, Paul Tudor Jones held 1,419 positions worth $3.09B, down 22% from $3.94B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Paul Tudor Jones withdrew a net $836M in Q1 2018, closing 452 positions and reducing 289 holdings. Its most notable exit was IXYS Corp, an estimated $7.19M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 5.5% a quarter earlier, followed by Financials and Industrials.

Against the trend, Paul Tudor Jones opened a new position in Orbital ATK, Inc. worth $30.4M.

  • Paul Tudor Jones's largest Q1 2018 buy was Orbital ATK, Inc.: 229,616 shares worth $30.4M.
  • Paul Tudor Jones added most to State Street SPDR S&P 500 ETF Trust in Q1 2018, an estimated $268M increase.
  • Paul Tudor Jones's biggest Q1 2018 reduction was JPMorgan Chase, cutting an estimated $5.97M.
  • Paul Tudor Jones fully exited IXYS Corp in Q1 2018, selling an estimated $7.19M.
  • Paul Tudor Jones's ten largest holdings make up 59% of its $3.09B portfolio in Q1 2018.
  • Paul Tudor Jones opened 356 new positions and closed 452 in Q1 2018.
  • Paul Tudor Jones's portfolio value fell 22% quarter-over-quarter to $3.09B.

Based on Tudor Investment Corp's 13F filing for Q1 2018, filed 15 May 2018.